v3.25.3
Restructuring, Business Transformation and Other Cost Saving Initiatives - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2023
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Employee
Sep. 30, 2024
USD ($)
Jun. 30, 2025
ft²
Sep. 30, 2023
ft²
Jul. 31, 2023
USD ($)
Restructuring Cost and Reserve [Line Items]                
Operating lease area | ft²           580,000    
Reata Pharmaceuticals, Inc                
Restructuring Cost and Reserve [Line Items]                
Operating lease area | ft²             327,400  
Lease term             16 years  
Maximum                
Restructuring Cost and Reserve [Line Items]                
Restructuring and Related Cost, Expected Cost Remaining               $ 310.0
2023 Cost Saving Initiatives                
Restructuring Cost and Reserve [Line Items]                
Expected operating expense reduction $ 1,000.0              
Expected number of positions eliminated | Employee       1,400        
Severance Costs   $ 7.4 $ 4.6 $ 41.6 $ 20.2      
2023 Cost Saving Initiatives | Restructuring charges                
Restructuring Cost and Reserve [Line Items]                
Severance Costs   7.4 4.6 41.6 20.2      
Reata Integration                
Restructuring Cost and Reserve [Line Items]                
Severance Costs   0.0 0.7 (0.2) 3.2      
Reata Integration | Minimum                
Restructuring Cost and Reserve [Line Items]                
Expected cost   35.0   35.0        
Reata Integration | Restructuring charges                
Restructuring Cost and Reserve [Line Items]                
Severance Costs   $ 0.0 $ 0.7 $ (0.2) $ 3.2